Brind.

Sab Biotherapeutics presented research at the EASD meeting, with Alexandra Kropotova as EVP and CMO and Christoph Bausch as COO.

1 report, 1 independent Updated Sep 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Sab Biotherapeutics presented research at the EASD meeting, with Alexandra Kropotova as EVP and CMO and Christoph Bausch as COO.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireSAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes MIAMI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- SAB Biotherapeutics